PODD Insulet Corporation
Health Care · S&P 500
Next earnings: not announced yet
What 28 analyst firms say about Insulet Corporation: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
26 rated views · 29 analyst/firm records · 28 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8052
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8052
Recent analyst activity · last 90 days
Our tracked history has 4 reports on PODD from 4 analyst firms in the last 90 days (28 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 1 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Barclays lowered its target from $198.00 (set 8 May 2026) to $150.00 on 7 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jeff Johnson | ConflictConflicting reports · excluded | 6 Aug 2026 | 175.00 USD |
| Bank of America Securities | Travis Steed | Buy | 18 May 2026 | 208.00 USD |
| Barclays | Christopher Pasquale | Hold | 7 Oct 2026 | 150.00 USD |
| Benchmark | Bruce D. Jackson | Buy | 6 Aug 2026 | 185.00 USD |
| Bernstein | Lee Hambright | Buy | 6 Aug 2026 | 175.00 USD |
| BTIG | Marie Thibault | Hold | 6 Aug 2026 | — |
| Canaccord Genuity | William Plovanic | Buy | 6 Aug 2026 | 179.00 USD |
| Citigroup | Joanne Wuensch | Hold | 8 Jul 2026 | Conflicting reports · excluded |
| Deutsche Bank | Kieran Ryan | Buy | 23 Jun 2026 | 190.00 USD |
| Evercore ISI | Daniel Markowitz | ConflictConflicting reports · excluded | 6 Jul 2026 | 180.00 USD |
| Goldman Sachs | David Roman | Buy | 27 May 2026 | 205.00 USD |
| Jefferies | Matthew Taylor | Buy | 12 Oct 2026 | 190.00 USD |
| JPMorgan | Robbie Marcus | Hold | 6 Aug 2026 | 152.00 USD |
| Leerink Partners | Mike Kratky | Hold | 6 Aug 2026 | Conflicting reports · excluded |
| Oppenheimer | Suraj Kalia | Hold | 5 Aug 2026 | — |
| Piper Sandler | Matthew O'Brien | Buy | 22 May 2026 | 160.00 USD |
| Raymond James | Jayson T Bedford | Buy | 8 Jun 2026 | 180.00 USD |
| RBC Capital Markets | Kendall Au | Buy | 23 Jul 2026 | 160.00 USD |
| RBC Capital Markets | Shagun Singh | Buy | 6 Aug 2026 | 160.00 USD |
| Redburn | Issie Kirby | Hold | 6 Aug 2026 | 165.00 USD |
| Stifel | Jonathan Block | Buy | 6 Aug 2026 | 180.00 USD |
| TD Cowen | Mathew Blackman | Hold | 6 Aug 2026 | 144.00 USD |
| Truist | Richard Newitter | Hold | 5 Aug 2026 | 153.00 USD |
| UBS | Patrick Wood | Hold | 6 Aug 2026 | 150.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Wells Fargo | Lawrence Biegelsen | Hold | 5 Aug 2026 | 144.00 USD |
| William Blair | Steven Lichtman | Buy | 27 Oct 2026 | — |
| Wolfe Research | Mike Polark | Buy | 6 Aug 2026 | 165.00 USD |
| Data feed RESEARCH | Research Team | Hold | 5 Jan 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:25 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.